Pay in 4 interest-free payments of $12.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
CUDC-907 was used at 0
4-tetrahydroquinazolin-6-yl)benzenesulfonamide
selective and orally bioavailable DYRK1A inhibitor with IC50 of 80 nM
92 µM toward JMJD2E
Br J Pharmacol
HCI-2509 (SP2509) - Reversible LSD1 Inhibitor. CAS# 1423715-09-6 054 CUDC-907 was used at 0HCI 2509 (also named as SP2509 or LSD1 C12) , CAS No. 1423715 09 6, is a highly potent, specific, and reversible Lysine Specific Demethylase 1 (LSD1) inhibitor. It inhibits LSD1 in biochemical assay with an IC50 ~13 nM, and has no activity against monoamine oxidase proteins MAO A and MAO B (>300 M). HCI 2509 is a non competitive inhibitor to bind LSD1, changes its solution dynamics in a manner distinct from TCP. It has minimal inhibition of CYPs and
US$ 148.00
US$ 39.99
US$ 90.00
US$ 46.00
US$ 199.00
US$ 19.99
US$ 150.00
US$ 150.00
US$ 135.00
US$ 160.00